InvestorsHub Logo
Followers 0
Posts 29
Boards Moderated 0
Alias Born 12/08/2019

Re: None

Saturday, 01/04/2020 3:16:29 PM

Saturday, January 04, 2020 3:16:29 PM

Post# of 1241
The biggest thing I keep seeing is....What's driving this to move? Ultimately, I don't know, but here are some theories:


1). Lumega-Z has been clinically proven to be better than AREDS-2 which is the leading ocular health vitamin (multi-million dollar product line for $BHC) and might get put on Amazon or Alibaba for mass market. Might see an $NBY type move if so. China has 20M+ suffering from macular degeneration.


2). Last patent run for MapcatSF in Hong Kong took the stock from $0.94 - $3 in a day. HK has 7.3M population. Company has been pursuing a patent in China/India for I believe 1 year+. Combined population of 2.7B people. Expecting this market to open up soon.


3). CSV-2000 launched in Nov. IR said sales were robust and actually required more parts to meet demand. 5000+ clinics used/use the CSV-1000. At a cost of $7,500, the company could sell 200+ and 10X revenue from a single product line. ER is in early Feb. (VectorVision site is actually down right now?)


4). Mega deal/partnership for GlaucoCetin which can reverse mitochondrial dysfunction, and can stop or reverse vision loss. (Is this real?!)


5). Mapcat/CSV-2000 military contract. Look up Don Gagliano, he's an executive at the company. He served in executive positions at the DoD and VA. He implemented billion dollar contracts for new medical contracts in the military. (whole team is impressive)


Company is currently priced to fail. They have solid products and might be just now getting their footing. We'll see!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GHSI News